Agitation in Alzheimer’s Disease Archives - Page 2 of 3

The Agitation In Alzheimer’s Screener For Caregivers (AASC™) Website

Article December 5, 2023

The Agitation in Alzheimer’s Screener for Caregivers (AASCTM) is a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders and was designed… Read More

The Agitation In Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition

On-Demand Webinar November 29, 2023

There’s a need for an easy, pragmatic screener to facilitate caregiver recognition of AAD and HCP discussions. AASC™, a brief screening tool based on the International Psychogeriatric Association (IPA) consensus… Read More

Combating Agitation In Alzheimer’s Dementia: Real World Approaches

Downloadable Resource November 7, 2023

Agitation in Alzheimer’s dementia worsens the impact of an already devastating and burdensome disease. It is associated with substantial patient burden and long term consequences. Read More

Agitation Associated With Alzheimer’s Dementia (AAD): A Focus On Stigma

Infographic September 8, 2023

In March 2023, we launched a survey of PsychU members to assess the stigma associated with AAD. This infographic summarizes the results of the survey. Over a 30-day period, 194… Read More

Addressing Inequalities In Agitation Among Disinvested Communities With Alzheimer’s Disease

On-Demand Webinar July 27, 2023

Explore with us, the barriers to treatment access and challenges faced by the medical community in delivering equitable care to agitated individuals with Alzheimer’s Disease from diverse backgrounds. Read More

Agitation Associated With Alzheimer’s Dementia: Mechanism Of Disease

Video May 16, 2023

Research has shown that in patients with Alzheimer’s dementia, agitation is associated with tau pathology and neurodegeneration in the prefrontal cortex and amygdala regions of the brain. Read More

Beyond Memory Loss: Optimizing The Role Of Primary Care In Assessing & Treating Agitation In Alzheimer’s Dementia

On-Demand Webinar May 11, 2023

This webinar dives into the unmet needs within this patient population and feature experts in the management of AAD within the primary care setting. Specifically, presenters review the prevalence of… Read More

Burden & Treatment Considerations For Agitation Associated With Alzheimer’s Dementia

On-Demand Webinar January 11, 2023

In this webinar, the speakers will review the burden of AAD, then discuss current treatment recommendations and unmet needs. Read More

Atypical Antipsychotics Bind To A Variety Of Neurotransmitter Receptors

Downloadable Resource November 18, 2022

An illustrative representation of different atypical antipsychotics and respective binding affinities are present in this graphic. The size of the circles indicates the level of binding affinity to each receptor… Read More

Pathophysiology Of Agitation Associated with Alzheimer’s Dementia: The Potential Role Of The Norepinephrine, Serotonin, & Dopamine (NSD) Neurotransmitter Systems

On-Demand Webinar October 26, 2022

Tau pathology and neurodegeneration in key prefrontal and subcortical brain regions may increase the risk of developing agitation in Alzheimer’s dementia. Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: